PROLAVERT Trademark

Trademark Overview

On Tuesday, September 15, 2015, a trademark application was filed for PROLAVERT with the United States Patent and Trademark Office. The USPTO has given the PROLAVERT trademark a serial number of 86756740. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 5, 2018. This trademark is owned by PrlA Pharma, Inc.. The PROLAVERT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical to act as a prolactin receptor antagonist to treat or prevent diseases, namely, lymphangioleiomymatosis and cancer
prolavert

General Information

Serial Number86756740
Word MarkPROLAVERT
Filing DateTuesday, September 15, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 5, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 9, 2016

Trademark Statements

Goods and ServicesPharmaceutical to act as a prolactin receptor antagonist to treat or prevent diseases, namely, lymphangioleiomymatosis and cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 18, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePrlA Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAustin, TX 78703
Party NamePrlA Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAustin, TX 78703

Trademark Events

Event DateEvent Description
Monday, November 5, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 5, 2018ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 27, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 23, 2018EXTENSION 4 GRANTED
Friday, March 23, 2018EXTENSION 4 FILED
Friday, March 23, 2018TEAS EXTENSION RECEIVED
Wednesday, September 13, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 11, 2017EXTENSION 3 GRANTED
Monday, September 11, 2017EXTENSION 3 FILED
Monday, September 11, 2017TEAS EXTENSION RECEIVED
Thursday, March 23, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 21, 2017EXTENSION 2 GRANTED
Tuesday, March 21, 2017EXTENSION 2 FILED
Tuesday, March 21, 2017TEAS EXTENSION RECEIVED
Friday, September 16, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 14, 2016EXTENSION 1 GRANTED
Wednesday, September 14, 2016EXTENSION 1 FILED
Wednesday, September 14, 2016TEAS EXTENSION RECEIVED
Tuesday, April 5, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 9, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 9, 2016PUBLISHED FOR OPPOSITION
Wednesday, January 20, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 4, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 30, 2015ASSIGNED TO EXAMINER
Friday, September 18, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 18, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

prolavert diseases namely lymphangioleiomymatosis cancer prevent treat prolactin receptor antagonist pharmaceutical